Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Chronic Inflammation: Introduction

Chronic Inflammation: Introduction

Chronic inflammation is a prolonged, dysregulated immune response that persists for weeks to years when the inciting stimulus is difficult to eradicate or when self‑antigens drive ongoing reactivity. Morphologically, it is defined by mononuclear cell infiltration, progressive tissue destruction, and concurrent attempts at healing via angiogenesis and fibrosis. Compared with acute inflammation, edema is less prominent while cellular infiltration predominates; triggers include persistent...

The JAK-STAT Signaling Pathway

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as SH2...

Inflammatory Response

Inflammatory Response

An inflammatory response is a localized, nonspecific immune reaction that occurs when a tissue is injured. It is characterized by redness, swelling, heat, and pain, which are commonly called the cardinal signs and symptoms of inflammation. Inflammation can sometimes result in a loss of function.
Inflammation can be triggered by various stimuli, such as impact, abrasion, chemical irritation, infections, and extreme hot or cold temperatures. These can damage cells and connective tissue fibers,...

Inflammatory Bowel Disease III: Crohn's Disease

Inflammatory Bowel Disease III: Crohn's Disease

Crohn’s disease is a chronic, relapsing form of inflammatory bowel disease characterized by segmental, transmural inflammation that can affect any part of the gastrointestinal tract. Its pathogenesis arises from a combination of genetic susceptibility, environmental exposures, epithelial barrier dysfunction, and immune dysregulation. Together, these factors lead to an exaggerated immune response against components of the gut microbiome.Genetic and Environmental InfluencesMultiple genetic...

T Cell Types and Functions

T Cell Types and Functions

When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...

Rheumatic Heart Disease I: Introduction

Rheumatic Heart Disease I: Introduction

Rheumatic heart disease or RHD is a chronic condition that results from rheumatic fever, causing permanent damage to the heart valves.Etiology and Risk FactorsIt primarily arises from rheumatic fever, an inflammatory disease that can develop after untreated or inadequately treated group A streptococcal (GAS) pharyngitis. Streptococcus spreads through direct contact with oral or respiratory secretions. While the bacteria are the causative agents, factors like malnutrition, overcrowding, poor...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

DNA (cytosine-5)-methyltransferase 3A (Dnmt3a) mutations limit normal and autoreactive CD4+ T follicular helper responses and attenuate T cell-driven joint inflammation.

Arthritis & rheumatology (Hoboken, N.J.)·2026

Same author

Variable fab domain N-glycosylation patterns in the B cell receptor repertoires of healthy individuals and patients with rheumatoid arthritis.

Journal of immunology (Baltimore, Md. : 1950)·2026

Same author

Targeting NFATc1-regulated MTHFD2 one-carbon metabolism to suppress sustained T-cell-mediated inflammation in rheumatoid arthritis.

Signal transduction and targeted therapy·2026

Same author

Thiol-reactive compound depletion reveals electrophile-dependent and independent anti-inflammatory constituents in <i>Saussurea costus</i>.

Frontiers in pharmacology·2026

Same author

Cell painting and thermal proteome profiling for inference of drug targets and mechanism of action.

Molecular systems biology·2026

Same author

Bioactivity-guided isolation of anti-inflammatory compounds from the herbs constituting a traditional Chinese medicine formulation used for the treatment of rheumatoid arthritis.

Phytomedicine : international journal of phytotherapy and phytopharmacology·2026

Same journal

Dysfunctional UBA1-mutated myeloid cells promote inflammation in VEXAS syndrome.

Nature reviews. Rheumatology·2026

Same journal

Targeting ferroptosis resistance in RA fibroblast-like synoviocytes.

Nature reviews. Rheumatology·2026

Same journal

Joint-specific susceptibility to inflammation is determined in utero.

Nature reviews. Rheumatology·2026

Same journal

Time to rethink the treatment of palindromic rheumatism.

Nature reviews. Rheumatology·2026

Same journal

Sensory nerves protect against tendon degeneration.

Nature reviews. Rheumatology·2026

Same journal

Publisher Correction: TLR7 in systemic lupus erythematosus: genetics and emerging therapies.

Nature reviews. Rheumatology·2026

See all related articles

Search research articles

Related Experiment Video

Updated: May 3, 2026

Analysis of Raw and Processed Cyperi Rhizoma Samples Using Liquid Chromatography-Tandem Mass Spectrometry in Rats with Primary Dysmenorrhea

Analysis of Raw and Processed Cyperi Rhizoma Samples Using Liquid Chromatography-Tandem Mass Spectrometry in Rats with Primary Dysmenorrhea

Published on: December 23, 2022

Persisting eicosanoid pathways in rheumatic diseases.

Marina Korotkova¹, Per-Johan Jakobsson¹

¹Rheumatology Unit, Department of Medicine, D2:01, Karolinska University Hospital, Solna, Karolinska Institutet, SE-17176 Stockholm, Sweden.

Nature Reviews. Rheumatology

|February 12, 2014

Summary

This summary is machine-generated.

Eicosanoids drive inflammation in rheumatic diseases. Targeting eicosanoid pathways offers new anti-inflammatory strategies for conditions like rheumatoid arthritis, potentially improving remission and reducing bone damage.

More Related Videos

In Vivo Imaging Uncovers the Migratory Behavior of Leukocytes within the Joints

In Vivo Imaging Uncovers the Migratory Behavior of Leukocytes within the Joints

Published on: December 9, 2025

Related Experiment Videos

Last Updated: May 3, 2026

Analysis of Raw and Processed Cyperi Rhizoma Samples Using Liquid Chromatography-Tandem Mass Spectrometry in Rats with Primary Dysmenorrhea

Analysis of Raw and Processed Cyperi Rhizoma Samples Using Liquid Chromatography-Tandem Mass Spectrometry in Rats with Primary Dysmenorrhea

Published on: December 23, 2022

In Vivo Imaging Uncovers the Migratory Behavior of Leukocytes within the Joints

In Vivo Imaging Uncovers the Migratory Behavior of Leukocytes within the Joints

Published on: December 9, 2025

Area of Science:

Rheumatology
Immunology
Biochemistry

Background:

Rheumatic diseases require better early treatments to maintain remission and prevent inflammation and bone destruction.
Eicosanoids are key regulators of inflammation, autoimmunity, and cancer, with dysregulated pathways implicated in rheumatic diseases.

Purpose of the Study:

To review the role of eicosanoid signaling in the pathogenesis of rheumatic diseases.
To discuss current and potential therapeutic strategies targeting eicosanoid pathways.

Main Methods:

Review of existing literature on eicosanoid pathways in rheumatic diseases.
Focus on rheumatoid arthritis, with discussion of other conditions like osteoarthritis, myopathies, lupus, and gout.

Main Results:

Evidence supports a pivotal role for eicosanoid signaling in rheumatic disease development.
Upregulation of cyclooxygenase and lipoxygenase pathways is noted in rheumatoid arthritis.
Research is expanding into the role of eicosanoids in other rheumatic conditions.

Conclusions:

Targeting eicosanoid pathways presents a promising avenue for novel anti-inflammatory treatments in rheumatic diseases.
Further research may lead to improved strategies for managing inflammation and preserving joint health.